ReviewGeoepidemiology, gender and autoimmune disease
Introduction
Autoimmune diseases (ADs) are a well-known cause of morbidity and mortality affecting approximately 6% of the western population [1], [2]. The study of the distribution of these conditions and the determinants of disease gradients across different regions and populations, otherwise known as geoepidemiology, indicates that incidence and prevalence of ADs are growing worldwide. Moreover, the frequency of ADs differs from country to country and geographic aggregates have been delineated [3]. Interest in these conditions is increasing as well, and the number of scientific publications has strongly risen over the last decade [4]. The importance of geoepidemiology does not lie solely in geographically delineating the burden of each disease, but also in advancing our understanding of its etiology, the mechanisms of immune disregulation, and triggering elements, which might ultimately enhance our ability to diagnose and treat [2], [3]. In this respect, an important body of research has pointed out the necessity, for autoimmunity to occur, of the combination of a susceptible genetic background with environmental triggers. Unfortunately large, international epidemiological investigations are lacking in the majority of ADs; on the other side, epidemiological data have been recently generated in countries with no previously available information.
In order to properly understand the geoepidemiology of ADs, it is important to consider that these disorders manifest a wide variability in terms of targeted tissues, age of onset, and response to immunosuppressive treatments. The one feature that is shared by the majority of these conditions, however, is the predominance in the female sex with over 80% of patients with AD being women [5]. The unbalanced sex ratio also varies significantly across the clinical spectrum and the more conspicuous sex differences are observed in Sjogren's syndrome, systemic lupus erythematosus (SLE) and primary biliary cirrhosis (PBC) [5]. Even though the female predisposition to AD has been known for over a century, the precise cause of this bias remains unknown and relatively few hypotheses have been proposed. Epidemiological studies have led to the identification of both genetic factors and environmental elements, as additional players in tolerance breakdown, to explain both ADs onset and the female predominance. Among sex-related factors that have been proposed, we note that sex hormones and reproductive history, fetal microchimerism, X chromosome inactivation; and X chromosome abnormalities have collected the most data. However, none of these hypotheses has thus far gathered enough convincing evidence and in most cases data are conflicting.
This review will critically describe geoepidemiological aspects related to the study of autoimmune conditions and its female prevalence. We will analyze the role of genetic and environmental factors in the so-called “geographical gradient”, and discuss geoepidemiological aspects about AD and its sex prevalence.
Section snippets
Geoepidemiology and autoimmunity
Analytical epidemiology deals with the concept of risk; indeed, distinguishing genetic elements from environmental injuries and identifying new potential risk factor for ADs development, is the effort of the clinical epidemiologist in autoimmunity [1]. Since incidence and prevalence of most ADs are not homogeneous, their frequency differs from country to country, and geographic aggregates have been delineated avoiding methodological errors is essential in order to compare epidemiological data
Sex prevalence
The most striking sex differences in autoimmune diseases are observed in Sjogren's syndrome, SLE, PBC, autoimmune thyroid disease (including both Hashimoto's and Graves' diseases) and scleroderma in which 80% of the patients are women. On the other hand, RA, MS and myasthenia gravis have a lower female prevalence but still 60% of the patients are women [46].
The effects of sex hormones on the immune function were first based on the reported role of estrogens in lymphocyte maturation, activation,
Concluding remarks and future directions
The field of autoimmunity is clearly showing how the findings of basic science influence routine clinical practice in terms of diagnostic procedures, clinical management and prediction of outcome. However, continuous effort should be performed and geoepidemiological studies and clustering analysis are essential tools to define the associated risk to single environmental and genetic factors. In particular, it will be important to collect additional information on the incidence and prevalence of
References (88)
- et al.
Geo-epidemiology and autoimmunity
J Autoimmun
(2010) - et al.
Defining and analyzing geoepidemiology and human autoimmunity
J Autoimmun
(2010) The worldwide gradient of autoimmune conditions
Autoimmun Rev
(2010)- et al.
The epidemiology of autoimmune diseases
Autoimmun Rev
(2003) - et al.
Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations
Gastroenterology
(2004) - et al.
The genetics of human autoimmune disease
J Autoimmun
(2009) Clustering and commonalities among autoimmune diseases
J Autoimmun
(2009)- et al.
Genetics of rheumatoid arthritis: underlying evidence of ethnic differences
J Autoimmun
(2009) - et al.
The Cd40, Ctla-4, Thyroglobulin, Tsh Receptor, and Ptpn22 Gene Quintet and its contribution to thyroid autoimmunity: back to the future
J Autoimmun
(2007) Future directions in genetic for autoimmune diseases
J Autoimmun
(2009)
Validation of Ckd and related conditions in existing data sets: a systematic review
Am J Kidney Dis
Developmental validation of the Powerplex 16 Hs System: an improved 16-locus fluorescent STR multiplex
Forensic Sci Int Genet
The geoepidemiology of systemic lupus erythematosus
Autoimmun Rev
The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis
Autoimmun Rev
Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review
Semin Arthritis Rheum
Multiple sclerosis: geoepidemiology, genetics and the environment
Autoimmun Rev
The geoepidemiology of type 1 diabetes
Autoimmun Rev
Frequency of monosomy X in women with primary biliary cirrhosis
Lancet
Gender as risk factor for autoimmune diseases
J Autoimmun
Strain variation in interferon gamma production of BCG-sensitized mice challenged with PPD II. importance of one major autosomal locus and additional sexual influences
Cell Immunol
Hyperprolactinemia and autoimmune diseases
Autoimmun Rev
Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (Il-4), Il-5, and gamma-interferon, but not Il-2 by activated murine T cells
Blood
Estrogen receptor-1 (Esr1) and − 2 (Esr2) regulate the severity of clinical experimental allergic encephalomyelitis in male mice
Am J Pathol
Microchimerism and Hla-compatible relationships of pregnancy in scleroderma
Lancet
Microchimerism in Japanese women patients with systemic sclerosis
Lancet
Turner's syndrome
Lancet
The implications of autoimmunity and pregnancy
J Autoimmun
Geoepidemiology of autoimmune rheumatic diseases
Nat Rev Rheumatol
Incidence and trends of childhood type 1 diabetes worldwide 1990–1999
Diabet Med
The demography of primary biliary cirrhosis in Ontario, Canada
Hepatology
Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study
Hepatology
Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients
Hepatology
Primary biliary cirrhosis once rare, now common in the United Kingdom?
Hepatology
Validation of coding algorithms for the identification of patients with primary biliary cirrhosis using administrative data
Can J Gastroenterol
Association of systemic lupus erythematosus with C8orf13-Blk and Itgam-Itgax
N Engl J Med
Association between type 1 diabetes and GWAS SNPs in the Southeast US Caucasian population
Genes Immun
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis
Nat Genet
Prediction of disease and phenotype associations from genome-wide association studies
PLoS One
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
Nat Genet
Common variants at Traf3ip2 are associated with susceptibility to psoriatic arthritis and psoriasis
Nat Genet
Recent advances in the genetics of autoimmune disease
Annu Rev Immunol
Validation of the intact rat weanling uterotrophic assay with notes on the formulation and analysis of the positive control chemical in vehicle
J Appl Toxicol
Validation of a DNA Quantitation Method on the Biomek(R) 3000
J Forensic Sci
Identification and validation of the pathways and functions regulated by the orphan nuclear receptor, Ror alpha1, in skeletal muscle
Nucleic Acids Res
Cited by (126)
Association between exposure to external airborne agents and autoimmune disease
2023, Ecotoxicology and Environmental SafetyAddressing the key issue: Antigen-specific targeting of B cells in autoimmune diseases
2023, Immunology LettersIntranasal gene therapy for the treatment of neurological disorders
2021, Direct Nose-to-Brain Drug Delivery: Mechanism, Technological Advances, Applications, and Regulatory UpdatesSafety, efficacy and prognostic impact of immune checkpoint inhibitors in older patients with genitourinary cancers
2020, Journal of Geriatric OncologyCitation Excerpt :Collectively, these studies strengthen the validity of the trend shown in our study. Although the underlying mechanism has not been resolved yet, a female predominance in many auto-immune diseases is well-known, implying a broader role of gender in immune-related disorders [38]. In sum, older patients had a comparable risk to develop immune-related toxicities as the younger cohort, confirming the tolerability and safety of IT in this commonly understudied, but prevalent group of patients.
Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment
2020, Journal of the American Academy of Dermatology